Palliative Chemotherapy Peer-review Journals

This idea of palliative chemotherapy is relatively new. It’s only in recent years that that alleviation of symptoms has become an important component of clinical trials for cancer research. Chemotherapy is a general term for the use of a chemical agent to stop cancer cells from growing. It can be administered in a variety of ways with the most common being: Orally-pills taken by mouth, Intravenously–infused through a vein, Topically– applied to the skin. Chemotherapy usually refers to chemical agents such as alkylating agents, anti-metabolites, and anti-tumor antibiotics. These chemicals are designed to kill cancer cells and prevent them from growing but they aren’t biased. They attack healthy cells as well, causing side effects such as nausea, hair loss, and infections. While not technically considered chemotherapy, other drugs may be used palliatively to shrink tumor size and slow cancer growth. They include hormone therapy and immunotherapy. Hormone therapy is the use of hormones to slow cancer growth, such as estrogen to slow cervical cancer, tamoxifen to slow breast cancer, and anti-androgens for prostate cancers. Immunotherapy is designed to stimulate the immune system to better recognize and attack cancer cells. For palliative purposes, most oncologists prefer to try the treatment with the least risk of side effects that would negatively impact quality of life. This means that hormone therapy may be tried before toxic chemotherapies. Peer review refers to the work done during the screening of submitted manuscripts and funding applications. This process encourages authors to meet the accepted standards of their discipline and reduces the dissemination of irrelevant findings, unwarranted claims, unacceptable interpretations, and personal views. Publications that have not undergone peer review are likely to be regarded with suspicion by academic scholars and professionals.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024